| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.865 | 0.002 | 0.906 | Anesthetic general | 0.862 0.002 DBMET00286 0.906 0.001 DBMET01727 | DBMET01727 | |
| 0.81 | 0.002 | 0.836 | Androgen antagonist | 0.671 0.003 DBMET00286 0.836 0.002 DBMET01727 | DBMET01727 | |
| 0.815 | 0.013 | 0.898 | Antiinflammatory | 0.794 0.016 DBMET00286 0.898 0.005 DBMET01727 | DBMET01727 | |
| 0.778 | 0.003 | 0.803 | Diuretic | 0.706 0.004 DBMET00286 0.803 0.003 DBMET01727 | DBMET01727 | |
| 0.745 | 0.001 | 0.745 | Aldosterone antagonist | 0.57 0.001 DBMET00286 0.735 0.001 DBMET01727 | ||
| 0.747 | 0.016 | 0.809 | Transcription factor NF kappa B inhibitor | 0.804 0.012 DBMET00286 0.809 0.012 DBMET01727 | DBMET01727 | |
| 0.732 | 0.006 | 0.788 | Cholesterol antagonist | 0.746 0.005 DBMET00286 0.788 0.004 DBMET01727 | DBMET01727 | |
| 0.72 | 0.004 | 0.72 | Growth factor agonist | 0.557 0.004 DBMET00286 0.426 0.005 DBMET01727 | ||
| 0.725 | 0.027 | 0.725 | Apoptosis agonist | 0.69 0.032 DBMET00286 0.654 0.038 DBMET01727 | ||
| 0.694 | 0.002 | 0.694 | Progesterone antagonist | 0.588 0.002 DBMET00286 0.552 0.002 DBMET01727 | ||
| 0.694 | 0.003 | 0.694 | NOS3 expression enhancer | 0.597 0.004 DBMET00286 0.63 0.004 DBMET01727 | ||
| 0.683 | 0.002 | 0.683 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.613 0.002 DBMET00286 0.328 0.003 DBMET01727 | ||
| 0.67 | 0.002 | 0.728 | Aromatase inhibitor | 0.728 0.002 DBMET00286 0.667 0.002 DBMET01727 | DBMET00286 | |
| 0.669 | 0.001 | 0.834 | Glucose-6-phosphate dehydrogenase inhibitor | 0.493 0.001 DBMET00286 0.834 0.001 DBMET01727 | DBMET01727 | |
| 0.648 | 0.005 | 0.718 | Hypoxia-inducible factor 1 alpha inhibitor | 0.558 0.01 DBMET00286 0.718 0.004 DBMET01727 | DBMET01727 | |
| 0.619 | 0.001 | 0.619 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.6 0.001 DBMET00286 0.546 0.001 DBMET01727 | ||
| 0.643 | 0.031 | 0.739 | Caspase 9 stimulant | 0.739 0.019 DBMET00286 0.672 0.027 DBMET01727 | DBMET00286 | |
| 0.605 | 0.001 | 0.605 | 5-Alpha-reductase 1 inhibitor | 0.411 0.002 DBMET00286 0.469 0.001 DBMET01727 | ||
| 0.588 | 0.002 | 0.588 | Lipocortins synthesis antagonist | 0.535 0.003 DBMET00286 0.548 0.003 DBMET01727 | ||
| 0.569 | 0.001 | 0.569 | 5-Alpha-reductase 2 inhibitor | 0.402 0.001 DBMET00286 0.424 0.001 DBMET01727 | ||
| 0.554 | 0.001 | 0.554 | 5-Alpha-reductase inhibitor | 0.431 0.002 DBMET00286 0.424 0.002 DBMET01727 | ||
| 0.556 | 0.004 | 0.693 | Aldehyde dehydrogenase inhibitor | 0.407 0.005 DBMET00286 0.693 0.003 DBMET01727 | DBMET01727 | |
| 0.545 | 0.022 | 0.624 | Immunosuppressant | 0.547 0.021 DBMET00286 0.624 0.01 DBMET01727 | DBMET01727 | |
| 0.521 | 0.005 | 0.544 | Interferon gamma antagonist | 0.511 0.005 DBMET00286 0.544 0.004 DBMET01727 | DBMET01727 | |
| 0.516 | 0.003 | 0.516 | Mineralocorticoid receptor antagonist | 0.318 0.004 DBMET00286 0.458 0.003 DBMET01727 | ||
| 0.515 | 0.007 | 0.564 | P-glycoprotein inhibitor | 0.564 0.005 DBMET00286 0.531 0.007 DBMET01727 | DBMET00286 | |
| 0.508 | 0.004 | 0.559 | Neurotrophic factor enhancer | 0.559 0.003 DBMET00286 0.387 0.006 DBMET01727 | DBMET00286 | |
| 0.503 | 0.004 | 0.513 | Sodium/bile acid cotransporter inhibitor | 0.513 0.003 DBMET00286 0.495 0.004 DBMET01727 | DBMET00286 | |
| 0.475 | 0.002 | 0.475 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.367 0.002 DBMET00286 0.291 0.002 DBMET01727 | ||
| 0.467 | 0.025 | 0.615 | Apoptosis antagonist | 0.578 0.012 DBMET00286 0.615 0.008 DBMET01727 | DBMET01727 | |
| 0.458 | 0.019 | 0.532 | Nitric oxide antagonist | 0.532 0.014 DBMET00286 0.419 0.023 DBMET01727 | DBMET00286 | |
| 0.448 | 0.016 | 0.454 | Interleukin 2 agonist | 0.407 0.025 DBMET00286 0.454 0.015 DBMET01727 | DBMET01727 | |
| 0.398 | 0.001 | 0.398 | RNA-directed RNA polymerase stimulant | 0.298 0.002 DBMET00286 0.34 0.002 DBMET01727 | ||
| 0.387 | 0.004 | 0.429 | Estrogen receptor alpha antagonist | 0.429 0.004 DBMET00286 0.288 0.005 DBMET01727 | DBMET00286 | |
| 0.385 | 0.005 | 0.398 | Cholesterol synthesis inhibitor | 0.398 0.004 DBMET00286 0.398 0.004 DBMET01727 | DBMET01727 | |
| 0.371 | 0.003 | 0.371 | Estradiol 17 beta-dehydrogenase inhibitor | 0.34 0.003 DBMET00286 0.227 0.004 DBMET01727 | ||
| 0.371 | 0.005 | 0.371 | Estrogen antagonist | 0.305 0.006 DBMET00286 0.314 0.005 DBMET01727 | ||
| 0.368 | 0.001 | 0.368 | Progesterone agonist | 0.243 0.002 DBMET00286 0.297 0.002 DBMET01727 | ||
| 0.366 | 0 | 0.637 | Transcortin receptor antagonist | 0.489 0 DBMET00286 0.637 0 DBMET01727 | DBMET01727 | |
| 0.356 | 0.009 | 0.537 | Antipruritic | 0.214 0.04 DBMET00286 0.537 0.004 DBMET01727 | DBMET01727 | |
| 0.349 | 0.004 | 0.349 | Farnesoid X receptor antagonist | 0.325 0.005 DBMET00286 0.316 0.005 DBMET01727 | ||
| 0.339 | 0.003 | 0.388 | Androgen agonist | 0.329 0.003 DBMET00286 0.388 0.003 DBMET01727 | DBMET01727 | |
| 0.333 | 0.002 | 0.352 | Glucocorticoid antagonist | 0.201 0.003 DBMET00286 0.352 0.002 DBMET01727 | DBMET01727 | |
| 0.324 | 0.001 | 0.362 | Arachidonic acid antagonist | 0.326 0.001 DBMET00286 0.362 0.001 DBMET01727 | DBMET01727 | |
| 0.324 | 0.002 | 0.324 | Glycine receptor agonist | 0.305 0.002 DBMET00286 0.277 0.003 DBMET01727 | ||
| 0.342 | 0.02 | 0.385 | Hepatoprotectant | 0.385 0.015 DBMET00286 0.3 0.03 DBMET01727 | DBMET00286 | |
| 0.315 | 0.002 | 0.335 | Glycine receptor antagonist | 0.335 0.002 DBMET00286 0.193 0.004 DBMET01727 | DBMET00286 | |
| 0.316 | 0.005 | 0.316 | Estrogen agonist | 0.269 0.005 DBMET00286 0.267 0.006 DBMET01727 | ||
| 0.308 | 0.004 | 0.308 | GABA receptor antagonist | 0.207 0.005 DBMET00286 0.231 0.005 DBMET01727 | ||
| 0.333 | 0.034 | 0.354 | Interleukin agonist | 0.317 0.04 DBMET00286 0.354 0.028 DBMET01727 | DBMET01727 | |
| 0.298 | 0.006 | 0.309 | GABA receptor agonist | 0.211 0.015 DBMET00286 0.309 0.005 DBMET01727 | DBMET01727 | |
| 0.29 | 0.005 | 0.29 | Hedgehog signaling inhibitor | 0.122 0.038 DBMET00286 0.19 0.013 DBMET01727 | ||
| 0.286 | 0.004 | 0.301 | Pregnane X receptor agonist | 0.301 0.004 DBMET00286 0.252 0.005 DBMET01727 | DBMET00286 | |
| 0.321 | 0.042 | 0.339 | Angiogenesis stimulant | 0.326 0.04 DBMET00286 0.339 0.036 DBMET01727 | DBMET01727 | |
| 0.288 | 0.023 | 0.288 | Melanin inhibitor | 0.256 0.028 DBMET00286 0.284 0.024 DBMET01727 | ||
| 0.268 | 0.004 | 0.268 | GABA A receptor antagonist | 0.173 0.007 DBMET00286 0.192 0.006 DBMET01727 | ||
| 0.267 | 0.005 | 0.267 | GABA A receptor agonist | 0.175 0.013 DBMET00286 0.256 0.005 DBMET01727 | ||
| 0.32 | 0.061 | 0.551 | Aldehyde oxidase inhibitor | 0.265 0.077 DBMET00286 0.551 0.026 DBMET01727 | DBMET01727 | |
| 0.302 | 0.044 | 0.302 | 5 Hydroxytryptamine uptake stimulant | 0.269 0.064 DBMET00286 0.226 0.109 DBMET01727 | ||
| 0.26 | 0.003 | 0.26 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.18 0.004 DBMET00286 0.26 0.003 DBMET01727 | ||
| 0.297 | 0.043 | 0.297 | Psychostimulant | 0.139 0.127 DBMET00286 0.285 0.047 DBMET01727 | ||
| 0.325 | 0.072 | 0.364 | Immunostimulant | 0.339 0.067 DBMET00286 0.364 0.06 DBMET01727 | DBMET01727 | |
| 0.242 | 0.004 | 0.26 | Bile acid receptor antagonist | 0.26 0.003 DBMET00286 0.208 0.004 DBMET01727 | DBMET00286 | |
| 0.239 | 0.002 | 0.246 | Anabolic | 0.246 0.002 DBMET00286 0.234 0.002 DBMET01727 | DBMET00286 | |
| 0.279 | 0.049 | 0.279 | Gastrin inhibitor | 0.265 0.063 DBMET00286 0.25 0.079 DBMET01727 | ||
| 0.25 | 0.023 | 0.289 | Interleukin 6 antagonist | 0.289 0.016 DBMET00286 0.239 0.025 DBMET01727 | DBMET00286 | |
| 0.245 | 0.018 | 0.248 | DNA polymerase I inhibitor | 0.247 0.017 DBMET00286 0.248 0.017 DBMET01727 | DBMET01727 | |
| 0.234 | 0.007 | 0.234 | Estrogen receptor beta antagonist | 0.194 0.01 DBMET00286 0.198 0.01 DBMET01727 | ||
| 0.324 | 0.101 | 0.413 | Antiobesity | 0.244 0.162 DBMET00286 0.413 0.061 DBMET01727 | DBMET01727 | |
| 0.213 | 0.004 | 0.213 | Estrogen receptor alpha agonist | 0.132 0.006 DBMET00286 0.167 0.005 DBMET01727 | ||
| 0.196 | 0.002 | 0.376 | Glucocorticoid agonist | 0.093 0.003 DBMET00286 0.376 0.001 DBMET01727 | DBMET01727 | |
| 0.203 | 0.01 | 0.212 | AMP-activated protein kinase stimulant | 0.212 0.009 DBMET00286 0.16 0.022 DBMET01727 | DBMET00286 | |
| 0.195 | 0.005 | 0.195 | Estrogen receptor beta agonist | 0.157 0.007 DBMET00286 0.171 0.005 DBMET01727 | ||
| 0.194 | 0.005 | 0.194 | Acetylcholine release stimulant | 0.109 0.068 DBMET00286 0.156 0.013 DBMET01727 | ||
| 0.221 | 0.034 | 0.221 | Lipid peroxidase inhibitor | 0.182 0.049 DBMET00286 0.211 0.037 DBMET01727 | ||
| 0.26 | 0.08 | 0.276 | Transcription factor STAT inhibitor | 0.276 0.07 DBMET00286 | DBMET00286 | |
| 0.182 | 0.003 | 0.197 | Na+ K+ transporting ATPase inhibitor | 0.195 0.002 DBMET00286 0.197 0.002 DBMET01727 | DBMET01727 | |
| 0.319 | 0.147 | 0.439 | Cyclophilin D inhibitor | 0.342 0.128 DBMET00286 0.439 0.071 DBMET01727 | DBMET01727 | |
| 0.25 | 0.08 | 0.314 | DNA damaging | 0.196 0.119 DBMET00286 0.314 0.052 DBMET01727 | DBMET01727 | |
| 0.25 | 0.084 | 0.305 | Antioxidant | 0.305 0.06 DBMET00286 0.253 0.082 DBMET01727 | DBMET00286 | |
| 0.196 | 0.033 | 0.196 | Anesthetic local | 0.125 0.063 DBMET00286 0.124 0.064 DBMET01727 | ||
| 0.189 | 0.028 | 0.301 | Adenylate cyclase inhibitor | 0.168 0.035 DBMET00286 0.301 0.013 DBMET01727 | DBMET01727 | |
| 0.161 | 0.003 | 0.161 | Estrone sulfatase inhibitor | 0.125 0.004 DBMET00286 0.142 0.004 DBMET01727 | ||
| 0.2 | 0.044 | 0.331 | Phospholipase C inhibitor | 0.331 0.016 DBMET00286 0.216 0.035 DBMET01727 | DBMET00286 | |
| 0.156 | 0.002 | 0.181 | Lipocortins synthesis agonist | 0.135 0.002 DBMET00286 0.181 0.001 DBMET01727 | DBMET01727 | |
| 0.224 | 0.07 | 0.232 | RNA-directed DNA polymerase inhibitor | 0.232 0.062 DBMET00286 0.21 0.085 DBMET01727 | DBMET00286 | |
| 0.16 | 0.015 | 0.16 | ABCA1 expression enhancer | 0.114 0.036 DBMET00286 0.154 0.016 DBMET01727 | ||
| 0.254 | 0.112 | 0.335 | Immunomodulator | 0.309 0.077 DBMET00286 0.335 0.065 DBMET01727 | DBMET01727 | |
| 0.16 | 0.018 | 0.16 | Acetylcholine nicotinic antagonist | 0.1 0.039 DBMET00286 0.092 0.044 DBMET01727 | ||
| 0.177 | 0.039 | 0.177 | Monophenol monooxygenase inhibitor | 0.165 0.042 DBMET00286 0.124 0.059 DBMET01727 | ||
| 0.165 | 0.031 | 0.212 | Microtubule formation inhibitor | 0.212 0.017 DBMET00286 0.159 0.033 DBMET01727 | DBMET00286 | |
| 0.183 | 0.05 | 0.271 | Amylase inhibitor | 0.161 0.059 DBMET00286 0.271 0.023 DBMET01727 | DBMET01727 | |
| 0.134 | 0.001 | 0.214 | Corticosteroid-like | 0.092 0.002 DBMET00286 0.214 0.001 DBMET01727 | DBMET01727 | |
| 0.144 | 0.014 | 0.144 | CDC25A inhibitor | 0.142 0.014 DBMET00286 0.14 0.014 DBMET01727 | ||
| 0.147 | 0.017 | 0.147 | Inducible nitric-oxide synthase inhibitor | 0.095 0.041 DBMET00286 0.108 0.031 DBMET01727 | ||
| 0.198 | 0.074 | 0.214 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.201 0.071 DBMET00286 0.214 0.062 DBMET01727 | DBMET01727 | |
| 0.128 | 0.008 | 0.15 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.101 0.011 DBMET00286 0.15 0.005 DBMET01727 | DBMET01727 | |
| 0.12 | 0.001 | 0.12 | Progesterone receptor A antagonist | 0.045 0.002 DBMET00286 0.042 0.002 DBMET01727 | ||
| 0.12 | 0.003 | 0.12 | Pregnane X receptor antagonist | 0.102 0.004 DBMET00286 0.116 0.003 DBMET01727 | ||
| 0.203 | 0.091 | 0.308 | Hypolipemic | 0.308 0.046 DBMET00286 0.254 0.065 DBMET01727 | DBMET00286 | |
| 0.161 | 0.05 | 0.193 | Neurotrophic factor | 0.193 0.031 DBMET00286 0.141 0.068 DBMET01727 | DBMET00286 | |
| 0.114 | 0.003 | 0.114 | GABA uptake inhibitor | 0.087 0.004 DBMET00286 0.102 0.004 DBMET01727 | ||
| 0.124 | 0.02 | 0.204 | Keratolytic | 0.145 0.015 DBMET00286 0.204 0.008 DBMET01727 | DBMET01727 | |
| 0.204 | 0.106 | 0.204 | Tumour necrosis factor alpha release inhibitor | 0.188 0.119 DBMET00286 0.176 0.129 DBMET01727 | ||
| 0.098 | 0.008 | 0.098 | Heme oxygenase stimulant | 0.087 0.011 DBMET00286 0.091 0.009 DBMET01727 | ||
| 0.224 | 0.138 | 0.371 | Caspase 3 stimulant | 0.371 0.053 DBMET00286 0.277 0.092 DBMET01727 | DBMET00286 | |
| 0.258 | 0.176 | 0.258 | Analgesic | 0.227 0.206 DBMET00286 | ||
| 0.119 | 0.039 | 0.119 | Prolactin inhibitor | 0.102 0.054 DBMET01727 | ||
| 0.127 | 0.053 | 0.132 | Interleukin 8 antagonist | 0.132 0.048 DBMET01727 | DBMET01727 | |
| 0.081 | 0.007 | 0.081 | Liver X receptor alpha agonist | 0.048 0.021 DBMET00286 0.079 0.007 DBMET01727 | ||
| 0.081 | 0.01 | 0.081 | Liver X receptor agonist | 0.045 0.028 DBMET00286 0.069 0.013 DBMET01727 | ||
| 0.076 | 0.005 | 0.076 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.054 0.006 DBMET00286 0.038 0.009 DBMET01727 | ||
| 0.115 | 0.048 | 0.123 | Toll-Like receptor 4 antagonist | 0.123 0.041 DBMET00286 0.117 0.047 DBMET01727 | DBMET00286 | |
| 0.143 | 0.076 | 0.171 | Adenylate cyclase stimulant | 0.171 0.034 DBMET00286 0.151 0.061 DBMET01727 | DBMET00286 | |
| 0.105 | 0.039 | 0.105 | Ornithine decarboxylase inhibitor | 0.1 0.045 DBMET00286 0.102 0.042 DBMET01727 | ||
| 0.126 | 0.063 | 0.176 | Alkylator | 0.156 0.044 DBMET00286 0.176 0.034 DBMET01727 | DBMET01727 | |
| 0.138 | 0.082 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.147 0.051 DBMET00286 0.144 0.061 DBMET01727 | DBMET00286 | |
| 0.154 | 0.101 | 0.21 | Platelet adhesion inhibitor | 0.21 0.066 DBMET00286 0.153 0.102 DBMET01727 | DBMET00286 | |
| 0.099 | 0.047 | 0.17 | Antineoplastic antibiotic | 0.17 0.027 DBMET00286 0.132 0.035 DBMET01727 | DBMET00286 | |
| 0.067 | 0.017 | 0.067 | Potassium channel Kv1.3 blocker | 0.055 0.025 DBMET00286 | ||
| 0.116 | 0.068 | 0.116 | Transcription factor STAT6 inhibitor | |||
| 0.127 | 0.079 | 0.144 | Bone formation stimulant | 0.144 0.064 DBMET01727 | DBMET01727 | |
| 0.089 | 0.042 | 0.102 | Estrogen-related receptor beta agonist | 0.086 0.05 DBMET00286 0.102 0.023 DBMET01727 | DBMET01727 | |
| 0.05 | 0.003 | 0.059 | Hedgehog signaling activator | 0.059 0.003 DBMET00286 0.047 0.004 DBMET01727 | DBMET00286 | |
| 0.047 | 0.001 | 0.047 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.036 0.001 DBMET00286 0.038 0.001 DBMET01727 | ||
| 0.057 | 0.014 | 0.057 | Parathyroid hormone antagonist | 0.056 0.014 DBMET00286 0.055 0.015 DBMET01727 | ||
| 0.05 | 0.01 | 0.05 | Liver X receptor beta agonist | 0.044 0.013 DBMET01727 | ||
| 0.132 | 0.093 | 0.132 | Acetylcholine M1 receptor antagonist | 0.128 0.097 DBMET01727 | ||
| 0.052 | 0.013 | 0.078 | Farnesoid X receptor agonist | 0.078 0.005 DBMET00286 0.05 0.015 DBMET01727 | DBMET00286 | |
| 0.135 | 0.097 | 0.135 | Sigma receptor agonist | |||
| 0.179 | 0.142 | 0.179 | 5 Hydroxytryptamine release stimulant | |||
| 0.085 | 0.051 | 0.085 | Opioid kappa receptor antagonist | 0.072 0.071 DBMET00286 0.085 0.051 DBMET01727 | ||
| 0.163 | 0.13 | 0.178 | Free radical scavenger | 0.178 0.116 DBMET00286 0.159 0.135 DBMET01727 | DBMET00286 | |
| 0.038 | 0.005 | 0.038 | Vitamin D receptor antagonist | 0.037 0.005 DBMET00286 0.036 0.005 DBMET01727 | ||
| 0.087 | 0.055 | 0.102 | Transcription factor NF kappa B stimulant | 0.102 0.037 DBMET00286 0.093 0.047 DBMET01727 | DBMET00286 | |
| 0.182 | 0.15 | 0.242 | DNA synthesis inhibitor | 0.206 0.114 DBMET00286 0.242 0.072 DBMET01727 | DBMET01727 | |
| 0.217 | 0.189 | 0.217 | Calcium channel activator | |||
| 0.052 | 0.025 | 0.058 | Microtubule stabilization | 0.058 0.018 DBMET00286 0.046 0.033 DBMET01727 | DBMET00286 | |
| 0.06 | 0.039 | 0.06 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.046 | 0.027 | 0.056 | Opioid kappa receptor agonist | 0.056 0.02 DBMET00286 | DBMET00286 | |
| 0.181 | 0.162 | 0.208 | Transcription factor STAT3 inhibitor | 0.208 0.123 DBMET00286 | DBMET00286 | |
| 0.024 | 0.008 | 0.024 | Progesterone receptor B antagonist | 0.018 0.015 DBMET00286 0.02 0.012 DBMET01727 | ||
| 0.103 | 0.089 | 0.103 | Acetylcholine antagonist | |||
| 0.026 | 0.013 | 0.026 | CYP24 inhibitor | 0.023 0.016 DBMET00286 0.021 0.019 DBMET01727 | ||
| 0.103 | 0.091 | 0.103 | Cholinergic antagonist | |||
| 0.019 | 0.007 | 0.028 | Vitamin D receptor agonist | 0.028 0.004 DBMET00286 0.022 0.005 DBMET01727 | DBMET00286 | |
| 0.112 | 0.101 | 0.157 | Protein kinase stimulant | 0.157 0.064 DBMET00286 0.127 0.086 DBMET01727 | DBMET00286 | |
| 0.077 | 0.07 | 0.115 | Antineoplastic alkaloid | 0.115 0.04 DBMET00286 0.077 0.069 DBMET01727 | DBMET00286 | |
| 0.017 | 0.011 | 0.025 | Telomerase stimulant | 0.025 0.004 DBMET00286 0.016 0.014 DBMET01727 | DBMET00286 | |
| 0.163 | 0.16 | 0.262 | Cardiotonic | 0.262 0.074 DBMET00286 | DBMET00286 | |
| 0.014 | 0.015 | 0.02 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.02 0.004 DBMET01727 | DBMET01727 | |
| 0.049 | 0.051 | 0.215 | HIV-1 integrase (Strand Transfer) inhibitor | 0.215 0.008 DBMET00286 0.051 0.049 DBMET01727 | DBMET00286 | |
| 0.03 | 0.036 | 0.038 | Tubulin agonist | 0.038 0.017 DBMET00286 | DBMET00286 | |
| 0.028 | 0.041 | 0.037 | HMG CoA reductase inhibitor | 0.037 0.019 DBMET00286 | DBMET00286 | |
| 0.084 | 0.098 | 0.123 | Protein-tyrosine phosphatase 1B inhibitor | 0.123 0.061 DBMET00286 | DBMET00286 | |
| 0.009 | 0.032 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 DBMET00286 | DBMET00286 | |
| 0.15 | 0.18 | 0.183 | Hypoglycemic | 0.183 0.13 DBMET00286 | DBMET00286 | |
| 0.04 | 0.093 | 0.067 | Nitric oxide donor | 0.067 0.037 DBMET01727 | DBMET01727 | |
| 0.023 | 0.078 | 0.06 | Adenosine deaminase inhibitor | 0.06 0.021 DBMET01727 | DBMET01727 | |
| 0.039 | 0.095 | 0.147 | HIV-1 integrase (3'-Processing) inhibitor | 0.147 0.014 DBMET00286 | DBMET00286 | |
| 0.065 | 0.121 | 0.13 | Interleukin 5 antagonist | 0.13 0.018 DBMET01727 | DBMET01727 | |
| 0.066 | 0.13 | 0.099 | Lanosterol 14 alpha demethylase inhibitor | 0.099 0.057 DBMET00286 | DBMET00286 | |
| 0.183 | 0.25 | 0.34 | Antibacterial | 0.34 0.108 DBMET00286 | DBMET00286 | |
| 0.074 | 0.159 | 0.105 | Cyclooxygenase 3 inhibitor | 0.105 0.095 DBMET01727 | DBMET01727 | |
| 0.111 | 0.206 | 0.148 | Succinate dehydrogenase inhibitor | 0.148 0.116 DBMET01727 | DBMET01727 | |
| 0.104 | 0.225 | 0.263 | Spasmolytic | 0.263 0.086 DBMET01727 | DBMET01727 | |
| 0.025 | 0.233 | 0.175 | Topoisomerase II alpha inhibitor | 0.175 0.019 DBMET01727 | DBMET01727 | |
| 0.02 | 0.261 | 0.055 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.043 DBMET00286 | DBMET00286 | |
| 0.046 | 0.368 | 0.121 | Interleukin 4 antagonist | 0.121 0.084 DBMET01727 | DBMET01727 | |
| 0.016 | 0.466 | 0.14 | Topoisomerase II inhibitor | 0.14 0.054 DBMET01727 | DBMET01727 | |
| 0.014 | 0.549 | 0.102 | DNA intercalator | 0.102 0.071 DBMET01727 | DBMET01727 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |